|
1
|
Cannistra SA: Cancer of the ovary. New
Engl J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shepherd JE: Current strategies for
prevention, detection, and treatment of ovarian cancer. J Am Pharm
Assoc. 40:392–401. 2000.
|
|
3
|
Agarwal R and Kaye SB: Ovarian cancer:
Strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haynes-Gimore N, Banach M, Brown E, Dawes
R, Edholm ES, Kim M and Robert J: Semi-solid tumor model in Xenopus
laevis/gilli cloned tadpoles for intravital study of
neovascularization, immune cells and melanophore infiltration. Dev
Biol. 408:205–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Facciabene A, Motz GT and Coukos G:
T-regulatory cells: Key players in tumor immune escape and
angiogenesis. Cancer Res. 72:2162–2171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou R, He PL, Ren YX, Wang WH, Zhou RY,
Wan H, Ono S, Fujiwara H and Zuo JP: Myeloid suppressor
cell-associated immune dysfunction in CSA1M fibrosarcoma
tumor-bearing mice. Cancer Sci. 98:882–889. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kiessling R, Wasserman K, Horiguchi S,
Kono K, Sjöberg J, Pisa P and Petersson M: Tumor-induced immune
dysfunction. Cancer Immunol Immunother. 48:353–362. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Yun R, Yu X, Hu H, Huang G, Tan B
and Chen T: Overexpression of Notch3 and pS6 is associated with
poor prognosis in human ovarian epithelial cancer. Mediators
Inflamm. 2016:59534982016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu H, Luo L, Liu F, Zou D, Zhu S, Tan B
and Chen T: Anti-cancer and sensibilisation effect of triptolide on
human epithelial ovarian cancer. J Cancer. 7:2093–2099. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Johnson SM, Wang X and Evers BM:
Triptolide inhibits proliferation and migration of colon cancer
cells by inhibition of cell cycle regulators and cytokine
receptors. J Surg Res. 168:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shu B, Duan W, Yao J, Huang J, Jiang Z and
Zhang L: Caspase 3 is involved in the apoptosis induced by
triptolide in HK-2 cells. Toxicol In Vitro. 23:598–602. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manzo SG, Zhou ZL, Wang YQ, Marinello J,
He JX, Li YC, Ding J, Capranico G and Miao ZH: Natural product
triptolide mediates cancer cell death by triggering CDK7-dependent
degradation of RNA polymerase II. Cancer Res. 72:5363–5373. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao H, Ma J, Guo T and Hu R: Triptolide
induces apoptosis of breast cancer cells via a mechanism associated
with the Wnt/β catenin signaling pathway. Exp Ther Med. 8:505–508.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Pan GF, Jiang ZZ, Yang J, Sun LX and
Zhang LY: Triptolide inhibits human breast cancer MCF-7 cell growth
via downregulation of the ERα-mediated signaling pathway. Acta
Pharmacol Sin. 36:606–613. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ziaei S and Halaby R: Immunosuppressive,
anti-inflammatory and anti-cancer properties of triptolide: A mini
review. Avicenna J Phytomed. 149–164. 2016.PubMed/NCBI
|
|
16
|
Zhong YY, Chen HP, Tan BZ, Yu HH and Huang
XS: Triptolide avoids cisplatin resistance and induces apoptosis
via the reactive oxygen species/nuclear factor-κB pathway in
SKOV3PT platinum-resistant human ovarian cancer cells.
Oncol Lett. 6:1084–1092. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xi C, Peng S, Wu Z, Zhou Q and Zhou J:
Toxicity of triptolide and the molecular mechanisms involved.
Biomed Pharmacother. 90:531–541. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and
Kim YH: Triptolide inactivates Akt and induces caspase-dependent
death in cervical cancer cells via the mitochondrial pathway. Int J
Oncol. 37:1177–1185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee KY, Park JS, Jee YK and Rosen GD:
Triptolide sensitizes lung cancer cells to TNF-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition
of NF-kappaB activation. Exp Mol Med. 34:462–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu W, Hu H, Qiu P and Yan G: Triptolide
induces apoptosis in human anaplastic thyroid carcinoma cells by a
p53-independent but NF-κB-related mechanism. Oncol Rep.
22:1397–1401. 2009.PubMed/NCBI
|
|
21
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng C, Chen T, Zhang Y and Chen Q:
Hedgehog signaling pathway regulates ovarian cancer invasion and
migration via adhesion molecule CD24. J Cancer. 8:786–792. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML,
Chang BW and Zhang YB: Notch3 overexpression associates with poor
prognosis in human non-small-cell lung cancer. Med Oncol.
30:5952013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mirone G, Perna S, Shukla A and Marfe G:
Involvement of Notch-1 in resistance to regorafenib in colon cancer
cells. J Cell Physiol. 231:1097–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berkenblit A and Cannistra SA: Advances in
the management of epithelial ovarian cancer. J Reprod Med.
50:426–438. 2005.PubMed/NCBI
|
|
27
|
Aggarwal BB, Sethi G, Baladandayuthapani
V, Krishnan S and Shishodia S: Targeting cell signaling pathways
for drug discovery: An old lock needs a new key. J Cell Biochem.
102:580–592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M, Huang J, Pan HZ and Jin J:
Triptolide overcomes dexamethasone resistance and enhanced
PS-341-induced apoptosis via PI3k/Akt/NF-κB pathways in human
multiple myeloma cells. Int J Mol Med. 22:489–496. 2008.PubMed/NCBI
|
|
29
|
Chen YW, Lin GJ, Chuang YP, Chia WT, Hueng
DY, Lin CK, Nieh S and Sytwu HK: Triptolide circumvents
drug-resistant effect and enhances 5-fluorouracil antitumor effect
on KB cells. Anticancer Drug. 21:502–513. 2010. View Article : Google Scholar
|
|
30
|
Carter BZ, Mak DH, Schober WD, McQueen T,
Harris D, Estrov Z, Evans RL and Andreeff M: Triptolide induces
caspase-dependent cell death mediated via the mitochondrial pathway
in leukemic cells. Blood. 108:630–637. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Z, Jin H, Xu R, Mei Q and Fan D:
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and
inhibits colitis-related colon cancer progression. Exp Mol Med.
41:717–727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei
XF, Yang J, Underhill CB and Zhang L: Triptolide inhibits the
growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72.
2003.PubMed/NCBI
|
|
33
|
Antonoff MB, Chugh R, Borja-Cacho D,
Dudeja V, Clawson KA, Skube SJ, Sorenson BS, Saltzman DA, Vickers
SM and Saluja AK: Triptolide therapy for neuroblastoma decreases
cell viability in vitro and inhibits tumor growth in vivo. Surgery.
146:282–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF,
Yeh JI and Hsu HY: Synergistic anticancer activity of triptolide
combined with cisplatin enhances apoptosis in gastric cancer in
vitro and in vivo. Cancer Lett. 319:203–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miyata Y, Sato T and Ito A: Triptolide, a
diterpenoid triepoxide, induces antitumor proliferation via
activation of c-Jun NH 2-terminal kinase 1 by decreasing
phosphatidylinositol 3-kinase activity in human tumor cells.
Biochem Biophys Res Commun. 336:1081–1086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou JR, Yu L, Mai Z and Blackburn GL:
Combined inhibition of estrogen-dependent human breast carcinoma by
soy and tea bioactive components in mice. Int J Cancer. 108:8–14.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Altieri DC: Molecular cloning of effector
cell protease receptor-1, a novel cell surface receptor for the
protease factor Xa. J Biol Chem. 269:3139–3142. 1994.PubMed/NCBI
|
|
38
|
Petersen SL, Wang L, Yalcin-Chin A, Li L,
Peyton M, Minna J, Harran P and Wang X: Autocrine TNFalpha
signaling renders human cancer cells susceptible to
Smac-mimetic-induced apoptosis. Cancer Cell. 12:445–456. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu Y, Jin X, Huang Y, Dong J, Wang H, Wang
X and Cao X: Inhibition of peritoneal metastasis of human gastric
cancer cells by dextran sulphate through the reduction in HIF-1α
and ITGβ1 expression. Oncol Rep. 35:2624–2634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Overall CM and López-Otín C: Strategies
for MMP inhibition in cancer: Innovations for the post-trial era.
Nat Rev Cancer. 2:657–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Swardfager W, Lanctôt K, Rothenburg L,
Wong A, Cappell J and Herrmann N: A meta-analysis of cytokines in
Alzheimer's disease. Biol Psychiat. 68:930–941. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liao W, Lin JX and Leonard WJ: IL-2 family
cytokines: New insights into the complex roles of IL-2 as a broad
regulator of T helper cell differentiation. Curr Opin Immunol.
23:598–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
